DiPiro's Pharmacotherapy (Record no. 29745)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04117nam a22003497a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241108110200.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241108110841.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241108b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-1-26-547342-6 |
| International Standard Book Number | 978-1-26-426454-4 |
| International Standard Book Number | 1-26-547342-0 |
| International Standard Book Number | 1-26-426454-2 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Joseph T. DiPiro |
| 222 ## - KEY TITLE | |
| Key title | DiPiro's Pharmacotherapy: A Pathophysiologic Approach |
| Qualifying information | ACE inhibitors ACEi activity acute adults adverse effects agents airway amiodarone angina anticoagulant antihypertensive apixaban ARB arrhythmias ASCVD aspirin assessment associated asthma atrial fibrillation bleeding blood pressure BP cardiac arrest Cardiovascular Disorders CCBs cells Chapter chest cholesterol chronic clinical trials clopidogrel Coll Cardiol contraception contraindicated COPD coronary corticosteroids cystic fibrosis dabigatran decrease diabetes digoxin diuretic dose drug dysfunction dyspnea efficacy eg Engl evaluated exacerbations fondaparinux function guidelines healthcare heart disease heart failure hemodynamic HF HFpEF HFrEF Hg hospital hyperkalemia hypotension improve increased inhaled initial INR ischemic LDL-C LMWH lung medication mg mmol/L monitoring mortality myocardial infarction oral outcomes oxygen PAH patients PCI pharmacologic Pharmacotherapy PharmD platelet PMID prevention pulmonary arterial hypertension receptor recommended reduce renal respiratory risk factors rivaroxaban serum SIHD sodium ẞ-blocker statin stroke symptoms syndrome Table tachycardia therapeutic therapy thiazide thromboembolism tion tissue treatment twice daily UFH vascular vasodilation venous ventricular VTE warfarin |
| 240 ## - UNIFORM TITLE | |
| Uniform title | DiPiro's Pharmacotherapy |
| 245 ## - TITLE STATEMENT | |
| Title | DiPiro's Pharmacotherapy |
| Remainder of title | A Pathophysiologic Approach. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 12th Edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | London | |
| Name of publisher, distributor, etc. | McGraw Hill LLC | |
| Date of publication, distribution, etc. | 2023. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 3331 Pages |
| Extent | Includes Index. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | A Doody's Core Title for 2023!<br/><br/>The #1 Textbook in Pharmacotherapy providing optimal patient outcomes using evidence-based medication therapies—updated with the latest advances and guidelines<br/><br/>For more than 30 years, DiPiro’s Pharmacotherapy has been the essential textbook for learning how to properly select, administer, and monitor drugs―everything needed to provide safe, effective drug therapy across all therapeutic categories. This new edition has been fully updated with the latest evidence-based information and recommendations.<br/><br/>With content from 300 expert contributors, this valuable resource offers detailed descriptions of common and uncommon disease states, including treatment by pharmacologic and non-pharmacologic means. Each disease chapter opens with a Patient Care Process, helping readers understand the collaborative care model in which pharmacists work and communicate with other healthcare providers for effective coordinated care.<br/><br/>Here's why DiPiro's Pharmacotherapy: A Pathophysiologic Approach is the perfect learning tool for students, pharmacists, and other healthcare providers:<br/><br/>All chapters provide the most current, reliable, and relevant information available Key concepts are included at the beginning of each chapter Clinical Presentation boxes concisely outline disease signs and symptoms New: Beyond the Book feature points readers to multimedia resources to deepen their understanding of the material Diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches clearly distinguish treatment pathways New: Drug monitoring tables have been added Patient care process boxes help readers know how to communicate with other health care providers New: Additional FREE E-Chapters are available on AccessPharmacy New: Over 2000 Review Questions to help prepare students! |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Pharmacology, Chemotherapy, Diseases, Drugs, Therapeutics. |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Fuller form of name | Gary C. Yee |
| Fuller form of name | Stuart T. Haines |
| Fuller form of name | Thomas D. Nolin |
| Fuller form of name | Vicki Ellingrod |
| Fuller form of name | L. Michael Posey |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 11/08/2024 | 20241108110200.0 | 11/08/2024 | 20241108110200.0 | 11/08/2024 | E-BOOKS |